Utility of the Alveolar-arterial Oxygen Gradient in Diagnosing Pulmonary Embolism

Clinical Question

How likely is a patient (in whom the possibility of a PE is being entertained) to have a pulmonary embolus if the A-a gradient is normal?

Clinical Bottom Line

  1. In a patient who you are considering the diagnosis of pulmonary embolism, the presence of a normal A-a gradient nearly rules out the likelihood of having a PE (high negative predictive value of a negative test, >90% -- especially in the absence of any previous history of DVT or PE -- or a negative LR of 0.10.)
  2. However, the converse is not true. The positive predictive value of an abnormal A-a gradient is <33%, and does not rule in a PE.

The Evidence

Derivation Set: All Patients

Pulmonary Embolism Predictive Value Likelihood Ratio
present absent
A-a gradient abnormal 104 364 0.22 1.13
normal 5 67 0.93 0.30
109 431 540

Derivation Set: Patients without previous DVT or PE

Pulmonary Embolism Predictive Value Likelihood Ratio
present absent
A-a gradient abnormal 82 307 0.21 1.17
normal 1 56 0.98 0.08
83 363 446

Validation Set: Patients without previous DVT or PE

Pulmonary Embolism Predictive Value Likelihood Ratio
present absent
A-a gradient abnormal 48 282 0.15 1.16
normal 1 53 0.98 0.13
49 335 384

Combined Derivation & Validation Sets: Patients without previous DVT or PE

Pulmonary Embolism Predictive Value Likelihood Ratio
present absent
A-a gradient abnormal 130 589 0.18 1.17
normal 2 109 0.98 0.10
132 698 830

Comments

  1. This was a well-intended study, however several flaws exist.
  2. There was no independent comparison of the test with the "gold standard", which in this case should have been the pulmonary angiogram. The presence or absence of a PE as recorded in the chart was accepted as correct. This was addressed fully in the comment section of the paper.
  3. There may be an element of incorporation or verification bias present as the authors do not clearly state whether or not the results of the ABG influenced the decision to perform the gold standard (which in this case was the V/Q scan.)
  4. They did create a derivation set of patient data, and confirm it against a validation set. The data were then combined and compared to each individually. There does not appear to be any significant difference except when comparing to the initial derivation sample which included all patients.
  5. Univariate analysis of the subgroups that showed increased risk of PE for a given risk factor (immobility, stroke, pulmonary disease, or previous DVT/PE) revealed good discrimination only for patients who did or did not have a previous history of DVT or PE.
  6. Despite the flaws in this paper, patients with a moderate to high suspicion of PE clinically should have an ABG performed. If it is normal, the LR for this (negative) test is 0.30 (considering all patients, not just those with no prior history of PE or DVT). For example, if your pre-test probability is 50 % of having a PE, the post-test probability is ~ 20%. If your pre-test probability is close to the prevalence reported in this study (~20%), then the post-test probability may be 5% or less. This has potential implications for cost savings and reducing the number of patients subjected to an invasive procedure like the VQ scan.

APPRAISED BY: Patrick Sousa, MD

DATE: September 4, 1996

McFarlane MJ and Imperiale TF. Use of the Alveolar-Arterial Oxygen Gradient in the Diagnosis of Pulmonary Embolism. Am J Med, 1994;96:57-62.